» Articles » PMID: 39595582

Molecular and Environmental Determinants of Addictive Substances

Overview
Journal Biomolecules
Publisher MDPI
Date 2024 Nov 27
PMID 39595582
Authors
Affiliations
Soon will be listed here.
Abstract

Knowledge about determinants of addiction in people taking addictive substances is poor and needs to be supplemented. The novelty of this paper consists in the analysis of innovative aspects of current research about relationships between determinants of addiction in Polish patients taking addictive substances and rare available data regarding the relationships between these factors from studies from recent years from other environments, mainly in Europe, and on the development of genetic determinants of physiological responses. We try to explain the role of the microelements Mn, Fe, Cu, Co, Zn, Cr, Ni, Tl, Se, Al, B, Mo, V, Sn, Sb, Ag, Sr, and Ba, the toxic metals Cd, Hg, As, and Pb, and the rare earth elements Sc, La, Ce, Pr, Eu, Gd, and Nd as factors that may shape the development of addiction to addictive substances or drugs. The interactions between factors (gene polymorphism, especially (), (), (, , , ), and ()) in patients addicted to addictive substances and consumption of vegetables, consumption of dairy products, exposure to harmful factors, and their relationships with physiological responses, which confirm the importance of internal factors as determinants of addiction, are analyzed, taking into account gender and region. The innovation of this review is to show that the homozygous mutant of the polymorphism may be a factor in increased risk of opioid dependence. We identify a variation in the functioning of the immune system in addicted patients from different environments as a result of the interaction of polymorphisms.

References
1.
Gong X, Wang J, Liu F, Yuan H, Zhang W, Guo Y . Gene polymorphisms of OPRM1 A118G and ABCB1 C3435T may influence opioid requirements in Chinese patients with cancer pain. Asian Pac J Cancer Prev. 2013; 14(5):2937-43. DOI: 10.7314/apjcp.2013.14.5.2937. View

2.
Oueslati B, Moula O, Ghachem R . The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review. Pharmacogenomics. 2018; 19(8):741-747. DOI: 10.2217/pgs-2018-0017. View

3.
Zahari Z, Salleh M, Zahri Johari M, Musa N, Ismail R . A Nested Allele-Specific Multiplex Polymerase Chain Reaction Method for the Detection of DRD2 Polymorphisms. Malays J Med Sci. 2012; 18(4):44-57. PMC: 3328935. View

4.
Ritchie T, Noble E . Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res. 2003; 28(1):73-82. DOI: 10.1023/a:1021648128758. View

5.
Ding S, Chen B, Zheng Y, Lu Q, Liu L, Zhuge Q . Association study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population. BMC Psychiatry. 2013; 13:107. PMC: 3641981. DOI: 10.1186/1471-244X-13-107. View